Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2026)

Twist Bioscience (TWST) has reported Cash from Investing Activities for 10 consecutive years, with -$10.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities fell 8.52% year-over-year to -$10.2 million in Q2 2026; TTM through Jun 2026 was -$45.2 million, a 231.57% decrease from a year earlier, with the FY2025 full-year figure at -$24.8 million, down 706.32% from the prior year.
• Cash from Investing Activities was -$10.2 million for Q2 2026 at Twist Bioscience, up from -$12.7 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $41.2 million in Q1 2023 and troughed at -$13.3 million in Q1 2022.
• A 5-year average of -$911444.4 and a median of -$1.9 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities surged 409.61% in 2023 and slumped 1221.66% in 2025, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$7.0 million in 2022, then soared by 159.75% to $4.2 million in 2023, then slumped by 136.88% to -$1.5 million in 2024, then sank by 546.68% to -$9.9 million in 2025, then decreased by 2.67% to -$10.2 million in 2026.
• The last three Cash from Investing Activities figures came in at -$10.2 million (Q2 2026), -$12.7 million (Q1 2026), and -$9.9 million (Q4 2025), per Business Quant data.